Skip to main content
Top
Published in: International Urology and Nephrology 6/2016

01-06-2016 | Nephrology - Original Paper

The accuracy of the anti-phospholipase A2 receptor antibody in the diagnosis of idiopathic membranous nephropathy: a comparison of different cutoff values as measured by the ELISA method

Authors: Yanna Dou, Li Zhang, Dong Liu, Chunyan Wang, Songxia Quan, Shuang Ma, Jing Xiao, Genyang Cheng, Zhangsuo Liu, Zhanzheng Zhao

Published in: International Urology and Nephrology | Issue 6/2016

Login to get access

Abstract

Aim

Recent studies have revealed that anti-phospholipase A2 receptor antibodies (aPLA2R-ABs) may play a role in the diagnosis of idiopathic membranous nephropathy (IMN). We will investigate the application of an aPLA2R-AB with different cutoff values for diagnosing IMN.

Methods

From August 2014 to December 2014, patients with proteinuria greater than 1 g/day were screened at the First Affiliated Hospital of Zhengzhou University. Patients were divided into the IMN and non-IMN groups based on the results of renal biopsy. The sensitivity, specificity, and receiver operating characteristic (ROC) curve of aPLA2R-AB for diagnosing IMN were analyzed.

Results

A total of 229 patients (113 males, average age of 45.3 ± 15.8 years) were enrolled in this study, and 118 patients were diagnosed with IMN. The sensitivity/specificity of aPLA2R-AB in the diagnosis of IMN was 65.3/97.3 %, 60.2/97.3 %, and 45.8/97.3 % for the different cutoff values (14, 20, and 40 RU/ml). The area of the ROC curve was 0.87.

Conclusion

Anti-PLA2R-AB with a cutoff value of 14 RU/ml based on the ELISA method plays an important role in the diagnosis of IMN.
Literature
1.
go back to reference Arias LF, Henao J, Giraldo RD, Carvajal N, Rodelo J, Arbelaez M (2009) Glomerular diseases in a Hispanic population: review of a regional renal biopsy database. Sao Paulo Med J 127(3):140–144CrossRefPubMed Arias LF, Henao J, Giraldo RD, Carvajal N, Rodelo J, Arbelaez M (2009) Glomerular diseases in a Hispanic population: review of a regional renal biopsy database. Sao Paulo Med J 127(3):140–144CrossRefPubMed
2.
go back to reference Chavez Valencia V, Orizaga de La Cruz C, Becerra Fuentes JG, Fuentes Ramirez F, Parra Michel R, Aragaki Y, Marquez Magana I, Pazarin Villasenor HL, Villanueva Perez MA, Garcia Cardenas MA (2014) Epidemiology of glomerular disease in adults: a database review. Gac Med Mex 150(5):403–408PubMed Chavez Valencia V, Orizaga de La Cruz C, Becerra Fuentes JG, Fuentes Ramirez F, Parra Michel R, Aragaki Y, Marquez Magana I, Pazarin Villasenor HL, Villanueva Perez MA, Garcia Cardenas MA (2014) Epidemiology of glomerular disease in adults: a database review. Gac Med Mex 150(5):403–408PubMed
3.
go back to reference Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. New Engl J Med 361(1):11–21CrossRefPubMedPubMedCentral Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. New Engl J Med 361(1):11–21CrossRefPubMedPubMedCentral
4.
go back to reference Rouault M, Le Calvez C, Boilard E, Surrel F, Singer A, Ghomashchi F, Bezzine S, Scarzello S, Bollinger J, Gelb MH et al (2007) Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor. Biochemistry 46(6):1647–1662CrossRefPubMed Rouault M, Le Calvez C, Boilard E, Surrel F, Singer A, Ghomashchi F, Bezzine S, Scarzello S, Bollinger J, Gelb MH et al (2007) Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor. Biochemistry 46(6):1647–1662CrossRefPubMed
5.
go back to reference Lambeau G, Ancian P, Barhanin J, Lazdunski M (1994) Cloning and expression of a membrane receptor for secretory phospholipases A2. J Biol Chem 269(3):1575–1578PubMed Lambeau G, Ancian P, Barhanin J, Lazdunski M (1994) Cloning and expression of a membrane receptor for secretory phospholipases A2. J Biol Chem 269(3):1575–1578PubMed
6.
go back to reference Hofstra JM, Debiec H, Short CD, Pelle T, Kleta R, Mathieson PW, Ronco P, Brenchley PE, Wetzels JF (2012) Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 23(10):1735–1743CrossRefPubMedPubMedCentral Hofstra JM, Debiec H, Short CD, Pelle T, Kleta R, Mathieson PW, Ronco P, Brenchley PE, Wetzels JF (2012) Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 23(10):1735–1743CrossRefPubMedPubMedCentral
7.
go back to reference Ardalan M, Ghafari A, Hamzavi F, Nasri H, Baradaran B, Majidi J, Nikbin B (2013) Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: a report from Iranian population. J Nephropathol 2(4):241–248PubMedPubMedCentral Ardalan M, Ghafari A, Hamzavi F, Nasri H, Baradaran B, Majidi J, Nikbin B (2013) Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: a report from Iranian population. J Nephropathol 2(4):241–248PubMedPubMedCentral
8.
go back to reference Ronco P, Debiec H, Imai H (2013) Circulating antipodocyte antibodies in membranous nephropathy: pathophysiologic and clinical relevance. Am J Kidney Dis 62(1):16–19CrossRefPubMed Ronco P, Debiec H, Imai H (2013) Circulating antipodocyte antibodies in membranous nephropathy: pathophysiologic and clinical relevance. Am J Kidney Dis 62(1):16–19CrossRefPubMed
9.
go back to reference Akiyama S, Akiyama M, Imai E, Ozaki T, Matsuo S, Maruyama S (2015) Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy. Clin Exp Nephrol 19(4):653–660CrossRefPubMed Akiyama S, Akiyama M, Imai E, Ozaki T, Matsuo S, Maruyama S (2015) Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy. Clin Exp Nephrol 19(4):653–660CrossRefPubMed
10.
go back to reference Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, Helmchen U, Stahl RA (2011) An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 26(8):2526–2532CrossRefPubMed Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, Helmchen U, Stahl RA (2011) An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 26(8):2526–2532CrossRefPubMed
11.
go back to reference Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z (2011) Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22(6):1137–1143CrossRefPubMedPubMedCentral Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z (2011) Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22(6):1137–1143CrossRefPubMedPubMedCentral
12.
go back to reference Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ (2011) Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6(6):1286–1291CrossRefPubMedPubMedCentral Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ (2011) Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6(6):1286–1291CrossRefPubMedPubMedCentral
13.
go back to reference Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS (2013) Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS ONE 8(4):e62151CrossRefPubMedPubMedCentral Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS (2013) Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS ONE 8(4):e62151CrossRefPubMedPubMedCentral
14.
go back to reference Timmermans SA, Damoiseaux JG, Heerings-Rewinkel PT, Ayalon R, Beck LH Jr, Schlumberger W, Salant DJ, van Paassen P, Tervaert JW, Limburg Renal R (2014) Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study. Am J Clin Pathol 142(1):29–34CrossRefPubMed Timmermans SA, Damoiseaux JG, Heerings-Rewinkel PT, Ayalon R, Beck LH Jr, Schlumberger W, Salant DJ, van Paassen P, Tervaert JW, Limburg Renal R (2014) Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study. Am J Clin Pathol 142(1):29–34CrossRefPubMed
15.
go back to reference Behnert A, Schiffer M, Muller-Deile J, Beck LH Jr, Mahler M, Fritzler MJ (2014) Antiphospholipase A(2) receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy. J Immunol Res 2014:143274CrossRefPubMedPubMedCentral Behnert A, Schiffer M, Muller-Deile J, Beck LH Jr, Mahler M, Fritzler MJ (2014) Antiphospholipase A(2) receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy. J Immunol Res 2014:143274CrossRefPubMedPubMedCentral
16.
go back to reference Dai J, Chen R, Meng X, Yang C, Zhao Z, Kan H (2015) Ambient air pollution, temperature and out-of-hospital coronary deaths in Shanghai, China. Environ Pollut 203:116–121CrossRefPubMed Dai J, Chen R, Meng X, Yang C, Zhao Z, Kan H (2015) Ambient air pollution, temperature and out-of-hospital coronary deaths in Shanghai, China. Environ Pollut 203:116–121CrossRefPubMed
Metadata
Title
The accuracy of the anti-phospholipase A2 receptor antibody in the diagnosis of idiopathic membranous nephropathy: a comparison of different cutoff values as measured by the ELISA method
Authors
Yanna Dou
Li Zhang
Dong Liu
Chunyan Wang
Songxia Quan
Shuang Ma
Jing Xiao
Genyang Cheng
Zhangsuo Liu
Zhanzheng Zhao
Publication date
01-06-2016
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 6/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1263-6

Other articles of this Issue 6/2016

International Urology and Nephrology 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine